Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia

American Journal of Medical Genetics

Volumn 137 A, Issue 2, 2005, Pages 153-160

  Cohen, Justine H ^a   Faughnan, Marie E ^a   Letarte, Michelle ^b,c   Vandezande, Kirk ^d   Kennedy, Shelley J ^b   Krahn, Murray D ^d,e,f  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

ALK 1; Cost; Cost benefit; Endoglin; ENG; Genetic; Hereditary hemorrhagic telangiecstasia

Indexed keywords

ENDOGLIN;

ADULT; AGED; ALK 1 GENE; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; FAMILY STUDY; GENE; GENETIC SCREENING; HEALTH CARE COST; HUMAN; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BRAIN; CHILD; COSTS AND COST ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC SCREENING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24344507129     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30838     Document Type: Article

References (32)

1. Abdalla SA, Letarte M. 2005. Hereditary haemorrhagic telangiectasia: Current views on genetics and mechanisms of disease. J Med Genet (in press).
2. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabeu C, Letarte M. 2000. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9:1227-1237.
3. Abdalla SA, Cymerman U, Johnson RM, Deber CM, Letarte M. 2003. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet 11:279-287.
4. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE, Jackson CE, Porteus MEM, Marchuk DA. 1997. The activin receptor-like kinase 1 gene: Genetic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60-67.
5. CCOHTA. 1997. Canadian coordinating office for health technology assessment guide: Canada. 2nd edn. Ottawa: Canadian Coordinating Office for Health Technology Assessment.
6. Cymerman U, Vera S, Pece-Barbara N, Bordeau A, White RL Jr, Dunn J, Letarte M. 2000. Identification of hereditary hemorrhagic telangiectasia type I in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 47:24-35.
7. Cymerman U, Vera S, Karabegovic A, Abdalla S, Letarte M. 2003. Characterization of several novel endoglin mutations associated with hereditary hemorrhagic telangiectasia. Human Mutation 21:482-492.
8. Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, Anthony KB, McAllister KA, Baldwin MA, Berg JN, Lux A, Smith JD, Vary CPH, Craighen WJ, Westermann CJJ, Warner ML, Miller YE, Jackson CE, Guttmacher AE, Marchuk DA. 1998. Mutation and expression analysis of the endoglin mutation in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutation 11:286-294.
9. Gallione CJ, Sheessele EA, Reinhardt D, Duits AJ, Berg JN, Westermann CJJ, Marchuk DA. 2000. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: Evidence for a founder effect. Hum Genet 107:40-44.
10. Gossage JR, Kanj G. 1998. Pulmonary arteriovenous malformations: A state of the art review. Am J Respir Crit Care Med 158:643-661.
11. Guttmacher A, Marchuk D, White RI. 1995. Hereditary hemorrhagic telangiecstasia. New Engl J Med 14:918-924.
12. Haitjema T, Disch F, Overtoom TTC, Westermann CJJ, Lammers JWJ. 1995. Screening family members of patients with hereditary hemorrhagic telangiecstasia. Am J Med 99:519-524.
13. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteous ME, Marchuk DA. 1995. A second locus for hereditary hemorrhagic telangiectasia mapped to chromosome 12. Genome Res 5:21-28.
14. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA. 1996. Mutations in activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nature Gen 13:189-195.
15. Kjeldsen AD, Brusgaard K, Poulsen L, Kruse T, Rasmussen K, Green A, Vase P. 2001. Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families. Am J Hum Genet 98:298-302.
16. Lastella P, Sabba C, Lenato GM, Lattanzi W, Gallitelli M, Cirulli A, Guanti G. 2003. Endoglin gene mutations and polymorphisms in Italian patients with hereditary hemorrhagic telangiectasia. Clin Genet 63: 536-540.
17. Lin WD, Wu JY, Hsu HB, Tsai FJ, Lee CC, Tsai CH. 2001. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation. J Formos Med Assoc 100:817-819.
18. Maher CO, Peipgras DG, Brown RDJ, Friedman JA, Pollock BE. 2001. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiecstasia. Stroke 32:877-882.
19. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrel J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type I. Nat Genet 8:345-351.
20. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteus ME, Guttmacher AE, Marchuk DA. 1995. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type I suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983-1985.
21. McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecker BB, Helmbold EA, Markel DS, Zolotor A, McKinnon WC, Vanderstoep JL, Jackson CE, Iannuzzi M, Collins FS, Boehnke M, Porteous ME, Guttmacher AE, Marchuk DA. 1994. A disease locus of hereditary hemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 6:197-204.
22. McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ. 2000. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 14:320-327.
23. Nanthakumar K, Hyland RH, Graham AT, Robinson TI, Grande P, Pugash RA, Clarke JA, Hutchison SJ, Mandzia JL, Faughnan ME. 2001. The use of agitated saline contrast echocardiography in detecting pulmonary arteriovenous malformations. Am Heart J 141:243-246.
24. Olivieri C, Mira E, Delu G, Pagella F, Zambelli A, Malvezzi L, Buscarini E, Danesino C. 2002. Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary hemorrhagic telangiectasia. J Med Genet; 39:39e
25. Ontario Health Insurance Schedule of Benefits. 2003. Ontario, Canada. Ottawa: Ministry of Health and Long Term Care.
26. Paquet ME, Pece-Barbara N, Vera S, Cymerman U, Karabegovic A, Shovlin C, Letarte M. 2001. Analysis of several endoglin mutant reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 10:1347-1357.
27. Pece N, Vera S, Cymerman U, White RIJ, Wrana JL, Letarte M. 1997. Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100:2568-2579.
28. Plauchu H, de Chaderevian JP, Bideau A, Robert J-M. 1989. Age-related profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291-297.
29. Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J, Seidman CE, Seidman JG. 1994. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205-209.
30. Shovlin CL, Hughes JMB, Scott J, Seidman CE, Seidman JG. 1997. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68-79.
31. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Nazzareno G, Loyd JE, Humbert M, Morrell NW. 2001. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325-334.
32. Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J. 1995. A third locus for hereditary hemorrhagic telangiectasia maps to chromosome 12q. Hum Molec Genet 4:945-949.